Lance D. Converse

Acurian, Inc. provides clinical trial patient recruitment and retention solutions for the life sciences industry. It offers recruitment feasibility, site identification and selection, patient recruitment and retention services. The firm also provides the recruitment manager platform or database that features feasibility and project management capabilities. The company was founded by Lance D. Converse, David Restrepo and Leslie D. Michelson in 1998 and is headquartered in Horsham, PA.

Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH.